Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,004 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparison of HLA-haploidentical donors with post-transplant cyclophosphamide versus HLA-matched unrelated donors in peripheral blood stem cell transplantation for acute myeloid leukaemia.
Moriguchi M, Nakamae H, Nishimoto M, Sugita J, Yanada M, Toubai T, Hasegawa Y, Hino M, Nishida T, Kurita N, Sawa M, Fukuda T, Jinguji A, Ota S, Matsuoka KI, Eto T, Hiramoto N, Ando T, Kawamura K, Kanda Y, Atsuta Y, Ohbiki M, Nakasone H, Konuma T. Moriguchi M, et al. Among authors: hino m. Br J Haematol. 2024 Dec;205(6):2376-2386. doi: 10.1111/bjh.19825. Epub 2024 Oct 22. Br J Haematol. 2024. PMID: 39439234
HLA-Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplantation Cyclophosphamide versus HLA-Matched Unrelated Donor Transplantation for Myelodysplastic Syndrome.
Nakaya Y, Koh H, Konuma T, Shimomura Y, Ishiyama K, Itonaga H, Hino M, Doki N, Nishida T, Ohigashi H, Matsuoka KI, Kanda Y, Maruyama Y, Sawa M, Eto T, Hiramoto N, Fukuda T, Atsuta Y, Nakamae H. Nakaya Y, et al. Among authors: hino m. Transplant Cell Ther. 2024 Mar;30(3):316.e1-316.e12. doi: 10.1016/j.jtct.2023.10.021. Epub 2023 Oct 30. Transplant Cell Ther. 2024. PMID: 38108263
Effect of peptide-binding motif on survival of HLA-haploidentical transplantation with post-transplant cyclophosphamide.
Ido K, Nakamae H, Hattori N, Kanaya M, Morita K, Hino M, Ohigashi H, Fukuda T, Eto T, Nagafuji K, Hiramoto N, Maruyama Y, Ota S, Matsuoka KI, Ando T, Akasaka T, Mori Y, Kamimura T, Kawakita T, Kawamura K, Kanda J, Onizuka M, Atsuta Y, Murata M. Ido K, et al. Among authors: hino m. Br J Haematol. 2024 Sep;205(3):1077-1096. doi: 10.1111/bjh.19630. Epub 2024 Jul 7. Br J Haematol. 2024. PMID: 38972374
Prospective observational study on the first 51 cases of peripheral blood stem cell transplantation from unrelated donors in Japan.
Goto T, Tanaka T, Sawa M, Ueda Y, Ago H, Chiba S, Kanamori H, Nishikawa A, Nougawa M, Ohashi K, Okumura H, Tanimoto M, Fukuda T, Kawashima N, Kato T, Okada K, Nagafuji K, Okamoto SI, Atsuta Y, Hino M, Tanaka J, Miyamura K. Goto T, et al. Among authors: hino m. Int J Hematol. 2018 Feb;107(2):211-221. doi: 10.1007/s12185-017-2341-y. Epub 2017 Oct 13. Int J Hematol. 2018. PMID: 29027623
Effect of allogeneic HCT from unrelated donors in AML patients with intermediate- or poor-risk cytogenetics: a retrospective study from the Japanese Society for HCT.
Yamasaki S, Mori J, Kanda J, Imahashi N, Uchida N, Doki N, Tanaka M, Katayama Y, Eto T, Ozawa Y, Takada S, Onizuka M, Hino M, Kanda Y, Fukuda T, Atsuta Y, Yanada M. Yamasaki S, et al. Among authors: hino m. Ann Hematol. 2020 Dec;99(12):2927-2937. doi: 10.1007/s00277-020-04261-6. Epub 2020 Sep 17. Ann Hematol. 2020. PMID: 32940726
A Prospective Study of an HLA-Haploidentical Peripheral Blood Stem Cell Transplantation Regimen Based on Modification of the Dose of Posttransplant Cyclophosphamide for Poor Prognosis or Refractory Hematological Malignancies.
Nakamae H, Okamura H, Hirose A, Koh H, Nakashima Y, Nakamae M, Nishimoto M, Makuuchi Y, Kuno M, Harada N, Takakuwa T, Hino M. Nakamae H, et al. Among authors: hino m. Cell Transplant. 2022 Jan-Dec;31:9636897221112098. doi: 10.1177/09636897221112098. Cell Transplant. 2022. PMID: 35906755 Free PMC article.
Severe short-term adverse events in related bone marrow or peripheral blood stem cell donors.
Yanagisawa R, Hirakawa T, Doki N, Ikegame K, Matsuoka KI, Fukuda T, Nakamae H, Ota S, Hiramoto N, Ishikawa J, Ara T, Tanaka M, Koga Y, Kawakita T, Maruyama Y, Kanda Y, Hino M, Atsuta Y, Yabe H, Tsukada N. Yanagisawa R, et al. Among authors: hino m. Int J Hematol. 2023 Mar;117(3):421-427. doi: 10.1007/s12185-022-03489-4. Epub 2022 Nov 20. Int J Hematol. 2023. PMID: 36403180
Posttransplant cyclophosphamide contributes to the impairment of the graft-versus-leukemia effect and the amelioration of graft-versus-host disease with the suppression of alloreactive T cells in a murine stem cell transplant model.
Makuuchi Y, Nakashima Y, Nishimoto M, Koh H, Hino M, Nakamae H. Makuuchi Y, et al. Among authors: hino m. Exp Hematol. 2023 Jul;123:56-65. doi: 10.1016/j.exphem.2023.04.003. Epub 2023 Apr 23. Exp Hematol. 2023. PMID: 37098360 Free article.
Posttransplantation cyclophosphamide mediates effective reconstitution of memory B cells after allogeneic hematopoietic cell transplantation.
Hayashi T, Nakashima Y, Takeda S, Nishimoto M, Okamura H, Takakuwa T, Kuno M, Makuuchi Y, Ido K, Sakatoku K, Horiuchi M, Koh H, Nakamae M, Hino M, Nakamae H. Hayashi T, et al. Among authors: hino m. Eur J Haematol. 2024 Nov;113(5):651-663. doi: 10.1111/ejh.14280. Epub 2024 Jul 28. Eur J Haematol. 2024. PMID: 39072897
Lower-dose post-transplant cyclophosphamide in haploidentical hematopoietic cell transplantation.
Fuji S, Nakamae H, Sugita J, Najima Y, Konishi T, Tanaka T, Nakashima Y, Nishimoto M, Okamura H, Nakayama K, Ito A, Yoshimitsu M, Hino M, Fukuda T, Atsuta Y, Yakushijin K. Fuji S, et al. Among authors: hino m. Bone Marrow Transplant. 2024 Nov;59(11):1628-1630. doi: 10.1038/s41409-024-02405-0. Epub 2024 Aug 26. Bone Marrow Transplant. 2024. PMID: 39187600 No abstract available.
1,004 results